U.S. Advanced Wound Care Market Overview:
The U.S. advanced wound care market size was valued at $3.35 billion in 2019 and is expected to reach $4.97 billion by 2027, registering a CAGR of 9.9% from 2020 to 2027.
Wound healing process can be facilitated in two different ways, namely, traditional wound care (TWC) and advanced wound care (AWC). Chronic wounds take more time to heal and are expensive to treat. Thus, advanced wound care is developing as a standard solution for treating chronic wounds. Moreover, traditional wound care products such as hydrocolloids, hydrogels, film & foam dressings, and alginates are increasingly being replaced with advanced wound care products, owing to their enhanced efficiency & effectiveness in managing wounds by enabling rapid healing. Moreover, they offer various advantages such as maintenance of a hydrated environment for appropriate flow of oxygen, temperature consistency, protection of wound site from exogenous infection, and ease in pain associated with dressing changes.
Chronic wounds are prevalent and costly to the U.S. health care system. According to a study by the Medicare beneficiaries, nearly 15% of beneficiaries have a chronic wound or infection every year, where most common chronic wounds are a result of diabetes and venous or arterial insufficiency. Furthermore, healthcare providers face major challenges in delivering care to wound patients during the COVID-19 pandemic. In addition, wound patients with multiple comorbidities are at an increased risk of infection of COVID-19.
The major factors that drive the U.S. advanced wound care market include rise in geriatric population and increase in incidences of diabetes, obesity, and chronic conditions. In addition, changes in healthcare system further drives growth of the market. However, high cost of wound care products is anticipated to hamper the market growth in the future. On the contrary, technological advancements to deal with complex wounds provide immense opportunities for market players.
U.S. Advanced Wound Care Market Segmentation
The U.S. advanced wound care market is segmented into product, application, and end user. By product, the market is categorized into infection management, exudate management, active wound care, and therapy devices. The infection management is sub segmented into silver dressings, non-silver dressings, and collagens. The exudate management segment is further divided into hydrocolloid dressings, foam dressings, alginate dressings, and hydrogel dressings. The active wound care segment is subdivided into skin substitutes and growth factors. The skin substitute segment is further segmented into xenograft, allografts, and cell-based bioengineering. The therapy devices segment is further segmented into negative pressure wound therapy (NPWT), oxygen & hyperbaric oxygen equipment, electromagnetic therapy devices, and others. Applications covered in the study include chronic wounds and acute wounds. The chronic wounds segment is further segregated into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and arterial ulcers. The acute wounds is further fragmented into burns & trauma, and surgical wounds. Depending on end user, the U.S. advanced wound care market is classified into hospitals and community health service centers.
Product segment review
On the basis product, the therapy devices segment acquired largest U.S. advanced wound care market share in 2019, owing to increase in the incidence rate of chronic diseases such as diabetes & obesity and rise in demand for innovative & advanced wound care products.
By Product
Therapy Devices segment holds the dominant position in 2019 and would continue to maintain the lead over the forecast period.
Application segment review
On the basis of application, the chronic wound segment is projected to exhibit the highest CAGR during the forecast period. This is attributed to surge in prevalence of post-operative surgical wounds, rise in geriatric population, increase in awareness and improved diagnosis, and technological advancements, which has driven demand for use of advanced wound care products worldwide.
By Application
Chronic Wounds is projected as one of the most lucrative segments.
The report provides a comprehensive analysis of the key players operating in the U.S. advanced wound care market, namely 3M (Acelity Inc.), Adynxx, Inc., B Braun Melsungen AG, Coloplast A/S, ConvaTec Group Plc, Essity AB (BSN Medical GmbH), Integra Lifesciences (Derma sciences), Investor AB (Mölnlycke Health Care AB), Johnson & Johnson, Medline Industries, Inc., Medtronic Plc., Organogenesis Holdings Inc., and Smith & Nephew Plc. The other players in the value chain include (profiles not included in the report) Paul Hartmann, Human Biosciences Inc., Kinetic Concept, Inc., and Mimedx Group.
Key Benefits For Stakeholders
- This report provides a detailed quantitative analysis of the current U.S. advanced wound care market trends and future estimations from 2020 to 2027, which assists in identifying the prevailing advanced wound care market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the market is provided.
- The key regulatory guidelines for the U.S. advanced wound care market are critically dealt across the country.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
U.S. Advanced Wound Care Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Application |
|
 By End User |
|
 Key Market Players | ESSITY AB (BSN MEDICAL GMBH), SMITH & NEPHEW PLC., MEDLINE INDUSTRIES, INC., CONVATEC GROUP PLC., COLOPLAST A/S, MEDTRONIC PLC., 3M (ACELITY INC.), INVESTOR AB (MÖLNLYCKE HEALTH CARE AB), JOHNSON & JOHNSON, B BRAUN MELSUNGEN AG, INTEGRA LIFESCIENCES (DERMA SCIENCES), ADYNXX, INC., ORGANOGENESIS HOLDINGS INC. |
Analyst Review
Advanced wound care therapies function on the principle of moisture therapy. This involves keeping a wound hydrated to facilitate faster healing. In addition, they are resistant to exogenous infections, and foreign particles.
Adoption of advanced wound care products such as hydrocolloids, hydrogels, film & foam dressings, and alginates is expected to witness significant growth, owing to rise in prevalence of chronic diseases such as diabetes and obesity. In addition, these products help to maintain a steady temperature around the wound, facilitate oxygen flow, relieve pain during dressing changes, and protect wounds from infection, which further fuels their demand in healthcare settings. Moreover, rise in adoption of evidence-based treatments for chronic wounds, problems associated with traditional wound healing methods, and attempts to reduce duration of hospital stays to lower healthcare expenses fuel growth of the U.S. advanced wound care market.
Active wound care products are most popularly used in advanced wound care therapy as these products stimulate new tissue growth, control infection & pain, and facilitate supply of nutrition to wounds. These products involve substances ranging from relatively low-tech collagen to high-tech artificial growth factors that enhance wound healing process. Thus, advanced wound care products are expected to witness increased adoption, owing to rise in number of plastic surgeries. Conversely, high cost of advanced wound care products is anticipated to act as a restraint for the market. However, increase in focus toward advanced treatment protocols is expected to open new avenues for expansion of the U.S. advanced wound care market.
The market value of global U.S. Advanced Wound Care market was $3.35 billion in 2019.
The forecast period is from 2020 to 2027.
The market value of global U.S. Advanced Wound Care market in 2020 is $2.57 billion.
The U.S. Advanced Wound Care market is expected to exhibit significant growth during the forecast period, due to the growth in geriatric population, rise in number of accidents, and increasing prevelance of diabetes, obesity, & chronic wounds across the U.S.
The base year is 2019 in U.S. Advanced Wound Care market
Based on applictaion, the chronic wounds segment held a major share in the U.S. Advanced Wound Care market in 2019 and is expected to continue the trend in the forecasting period.
Loading Table Of Content...
